Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4206409
Max Phase: Preclinical
Molecular Formula: C20H22N4O3
Molecular Weight: 366.42
Molecule Type: Small molecule
Associated Items:
ID: ALA4206409
Max Phase: Preclinical
Molecular Formula: C20H22N4O3
Molecular Weight: 366.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC(=O)c1cc(Oc2c(C)cc(-c3noc(C(C)C)n3)cc2C)ccn1
Standard InChI: InChI=1S/C20H22N4O3/c1-11(2)20-23-18(24-27-20)14-8-12(3)17(13(4)9-14)26-15-6-7-22-16(10-15)19(25)21-5/h6-11H,1-5H3,(H,21,25)
Standard InChI Key: UAHHWNAURYQQNC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.42 | Molecular Weight (Monoisotopic): 366.1692 | AlogP: 4.02 | #Rotatable Bonds: 5 |
Polar Surface Area: 90.14 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.99 | CX Basic pKa: 3.02 | CX LogP: 4.16 | CX LogD: 4.16 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.73 | Np Likeness Score: -1.25 |
1. Kim J, Shin JS, Ahn S, Han SB, Jung YS.. (2018) 3-Aryl-1,2,4-oxadiazole Derivatives Active Against Human Rhinovirus., 9 (7): [PMID:30034598] [10.1021/acsmedchemlett.8b00134] |
Source(1):